Skip to main content

EDITORIAL article

Front. Toxicol., 20 July 2022
Sec. Developmental and Reproductive Toxicology
This article is part of the Research Topic Methods and Protocols in Developmental and Reproductive Toxicology View all 5 articles

Editorial: Methods and Protocols in Developmental and Reproductive Toxicology

  • 1National Research Center for the Working Environment, Copenhagen, Denmark
  • 2Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
  • 3National Food Institute, Technical University of Denmark, Kgs. Lyngy, Denmark

Undisturbed reproductive development is a prerequisite for life-long reproductive health. Many stages of perinatal life are vulnerable to disturbances such as exposure to environmental chemicals and drugs that can interfere with molecular and cellular processes. Of concern is the enormous number of chemicals and pharmaceuticals in existence and for which humans and wildlife can be exposed through their life cycles (Rockström et al., 2009; Svingen and Vinggaard, 2016; Hougaard, 2021).

Although there are international regulations and guidelines in place for testing and assessing chemical substances for their potential toxicity, they are in many ways inadequate in dealing with the vast number of chemicals in use coupled with the myriad of potential effect they can have on complex living organisms. This challenge is becoming even more pressing with modern toxicology moving towards higher dependence on alternative test methods rather than more traditional large-scale animal toxicity testing for screening and prioritizing chemical substances of concern (Pistollato et al., 2021). This is not least important in hypothesis-driven testing, or predictive toxicology, where knowledge about toxicological mechanisms and measurable key events increasingly feed into causal adverse outcome pathways (AOPs) (Ankley & Edwards, 2018; Audouze et al., 2021; Paini et al., 2022; Svingen et al., 2022). Once robust AOPs have been developed, chemicals can increasingly be assessed using alternative methods; in essence reducing the reliance on more traditional in vivo (animal) protocols. Thus, to ensure a safe environment for future generations, we need methods that can cut down on resources needed to carry out scientific research and enable hazard identification and safety assessment based on limited, or even no testing, in complex biological systems. The 21st Century has witnessed great strides towards this endeavor and this development will undoubtedly continue to move in the right direction. Yet, limitations with reductionist methodologies must simultaneously be considered when devising testing strategies relying on alternative test methods to properly account for emergent properties in complex organisms (Svingen, 2022).

Standardized and validated protocols are critically important in regulatory toxicology. However, formal validation and acceptance of new methods for hazard assessment, such as under the Organization for Economic Co-operation and Development (OECD), is laborious and time-consuming. Common guidelines for the reporting of experimental results are also very useful, but only if endorsed by the scientific community. Here, scientific journals play a role in providing a forum where scientists across sub-disciplines of toxicology can share methods and protocols that are tried and tested. This can encourage dialogue on ways by which toxicological research is conducted. On this background, we invited contributions on methods and protocols in developmental and reproductive toxicology to hopefully in the longer term improve our capacity to test and assess chemical substances in a reproducible and widely accepted manner.

This Research Topic collected four method papers addressing reproductive and developmental toxicity.

The first paper Hoyberghs et al. deals with optimization of the Zebrafish Embryo Developmental Toxicity Assay (ZEDTA), specifically on the optimal concentration of (DMSO), which is often used as a chemical solvent. Since high concentrations of DMSO is toxic to zebrafish larvae and embryos, it is imperative to keep DMSO concentrations below toxic levels when testing for potential effects of chemicals to avoid false positives. The maximum DMSO concentration of 0.01% that is recommended by the OECD may, however, in many instances be too low to dissolve test compounds. In contrast to OECD recommendations, this study shows that a DMSO concentration up to 1% is non-toxic in the ZEDTA assay Hoyberghs et al., a finding that will have direct impact on how the assay is performed and which chemicals that can be tested.

The second paper Garner et al. addresses how the isolated rat placenta can be used to assess fetoplacental hemodynamics. The ex vivo application of isolated placentas is well described for both animals and humans in the assessment of passage of chemicals between the maternal and fetal compartment. However, perturbations in for instance placental blood flow might lead to poor health outcomes for both the dam and the fetus. This paper describes a technique that allows for control of inflow pressure and analysis of resulting placental outflow pressure and flow in rat placentas by use of a modified pressure myography chamber. Hence, the model allows for characterization of changes in placental hemodynamics, for example as a consequence of chemical exposure during gestation Garner et al.

The third paper Onoda et al. reports on a novel method for detecting brain perivascular injuries, whereby periodic acid-schiff is combined with immunohistochemical staining in a double-staining protocol to increase sensitivity. Brain development is sensitive to perturbation by chemical exposures and the authors have previously shown brain perivascular tissues, and macrophages, to be particularly sensitive to maternal nanoparticle exposure during gestation (Onoda et al., 2017a; Onoda et al., 2017b). The authors propose that their improved staining method of tissues in close proximity to brain blood vessels can be used to evaluate developmental neurotoxicity Onoda et al.

The final paper Asimaki et al. describes a method for application in screening of chemicals for female reproductive toxicity, the bovine model of in vitro oocyte maturation with subsequent production of embryos, including events in oocyte maturation and acquisition of developmental competence. The model includes the in vitro maturation of cumulus-oocyte complexes followed by in vitro fertilization by co-incubation of oocytes with sperm, and subsequent in vitro embryo culture until the blastocyst stage. Endpoints represent important aspects of oocyte maturation and embryo development such as nuclear maturation, mitochondrial redistribution, cumulus cell expansion, apoptosis, and steroidogenesis, and in fertilized oocytes, embryo cleavage and blastocyst rates Asimaki et al.

The submitted papers on methods and protocols in developmental and reproductive toxicology describe both existing methods that were adapted for specific purposes, as well as new methods addressing novel aspects of developmental toxicity testing. Hopefully, they will in the longer term improve assessment of chemical substances within this field toxicology.

Author Contributions

KH and TS drafted, edited and agreed on final version of the manuscript.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

Ankley, G. T., and Edwards, S. W. (2018). The Adverse Outcome Pathway: A Multifaceted Framework Supporting 21st Century Toxicology. Curr. Opin. Toxicol. 9, 1–7. doi:10.1016/j.cotox.2018.03.004

PubMed Abstract | CrossRef Full Text | Google Scholar

Audouze, K., Zgheib, E., Abass, K., Baig, A. H., Forner-Piquer, I., Holbech, H., et al. (2021). Evidenced-Based Approaches to Support the Development of Endocrine-Mediated Adverse Outcome Pathways: Challenges and Opportunities. Front. Toxicol. 3, 787017. doi:10.3389/ftox.2021.787017

PubMed Abstract | CrossRef Full Text | Google Scholar

Hougaard, K. S. (2021). Next Generation Reproductive and Developmental Toxicology: Crosstalk into the Future. Front. Toxicol. 3, 652571. doi:10.3389/ftox.2021.652571

PubMed Abstract | CrossRef Full Text | Google Scholar

Onoda, A., Kawasaki, T., Tsukiyama, K., Takeda, K., and Umezawa, M. (2017a). Perivascular Accumulation of β-Sheet-Rich Proteins in Offspring Brain Following Maternal Exposure to Carbon Black Nanoparticles. Front. Cell. Neurosci. 11, 92. doi:10.3389/fncel.2017.00092

PubMed Abstract | CrossRef Full Text | Google Scholar

Onoda, A., Takeda, K., and Umezawa, M. (2017b). Dose-dependent Induction of Astrocyte Activation and Reactive Astrogliosis in Mouse Brain Following Maternal Exposure to Carbon Black Nanoparticle. Part Fibre Toxicol. 14, 4. doi:10.1186/s12989-017-0184-6

PubMed Abstract | CrossRef Full Text | Google Scholar

Paini, A., Campia, I., Cronin, M. T. D., Asturiol, D., Ceriani, L., Exner, T. E., et al. (2022). Towards a qAOP Framework for Predictive Toxicology - Linking Data to Decisions. Comput. Toxicol. 21, 100195. doi:10.1016/j.comtox.2021.100195

PubMed Abstract | CrossRef Full Text | Google Scholar

Pistollato, F., Madia, F., Corvi, R., Munn, S., Grignard, E., Paini, A., et al. (2021). Current EU Regulatory Requirements for the Assessment of Chemicals and Cosmetic Products: Challenges and Opportunities for Introducing New Approach Methodologies. Arch. Toxicol. 95, 1867–1897. doi:10.1007/s00204-021-03034-y

PubMed Abstract | CrossRef Full Text | Google Scholar

Rockström, J., Steffen, W., Noone, K., Persson, A., Chapin, F. S., Lambin, E. F., et al. (2009). A Safe Operating Space for Humanity. Nature 461, 472–475. doi:10.1038/461472a

PubMed Abstract | CrossRef Full Text | Google Scholar

Svingen, T. (2022). Endocrine Disruptors in a New Era of Predictive Toxicology and Dealing with the "More Is Different" Challenge. Front. Toxicol. 4, 900479. doi:10.3389/ftox.2022.900479

PubMed Abstract | CrossRef Full Text | Google Scholar

Svingen, T., Schwartz, C. L., Rosenmai, A. K., Ramhøj, L., Johansson, H. K. L., Hass, U., et al. (2022). Using Alternative Test Methods to Predict Endocrine Disruption and Reproductive Adverse Outcomes: Do We Have Enough Knowledge? Environ. Pollut. 304, 119242. doi:10.1016/j.envpol.2022.119242

PubMed Abstract | CrossRef Full Text | Google Scholar

Svingen, T., and Vinggaard, A. M. (2016). The Risk of Chemical Cocktail Effects and How to Deal with the Issue. J. Epidemiol. Community Health 70, 322–323. doi:10.1136/jech-2015-206268

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: new approach methodologies (NAM), chemical test method, adverse outcome pathway (AOP), mechanisms, predictive toxicity assay, development

Citation: Hougaard KS and Svingen T (2022) Editorial: Methods and Protocols in Developmental and Reproductive Toxicology. Front. Toxic. 4:948103. doi: 10.3389/ftox.2022.948103

Received: 19 May 2022; Accepted: 20 June 2022;
Published: 20 July 2022.

Edited and reviewed by:

Steven Jan Van Cruchten, University of Antwerp, Belgium

Copyright © 2022 Hougaard and Svingen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Terje Svingen, tesv@food.dtu.dk

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.